Charles Ryhee
Stock Analyst at TD Cowen
(2.43)
# 2,451
Out of 5,147 analysts
17
Total ratings
60%
Success rate
10.88%
Average return
Main Sectors:
Stocks Rated by Charles Ryhee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Buy | $73 → $80 | $79.90 | +0.13% | 5 | Nov 25, 2024 | |
| MCK McKesson | Maintains: Buy | $563 → $652 | $987.37 | -33.97% | 4 | May 8, 2024 | |
| CVX Chevron | Maintains: Outperform | $185 → $170 | $186.76 | -8.97% | 3 | Feb 24, 2023 | |
| EVH Evolent Health | Maintains: Outperform | $57 → $59 | $3.25 | +1,715.38% | 2 | Jan 30, 2023 | |
| CAH Cardinal Health | Maintains: Market Perform | $59 → $72 | $229.23 | -68.59% | 1 | Aug 16, 2022 | |
| TDOC Teladoc Health | Maintains: Outperform | $240 → $188 | $5.26 | +3,474.14% | 1 | Aug 9, 2021 | |
| OSCR Oscar Health | Initiates: Market Perform | $29 | $13.64 | +112.61% | 1 | Mar 29, 2021 |
CVS Health
Nov 25, 2024
Maintains: Buy
Price Target: $73 → $80
Current: $79.90
Upside: +0.13%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $563 → $652
Current: $987.37
Upside: -33.97%
Chevron
Feb 24, 2023
Maintains: Outperform
Price Target: $185 → $170
Current: $186.76
Upside: -8.97%
Evolent Health
Jan 30, 2023
Maintains: Outperform
Price Target: $57 → $59
Current: $3.25
Upside: +1,715.38%
Cardinal Health
Aug 16, 2022
Maintains: Market Perform
Price Target: $59 → $72
Current: $229.23
Upside: -68.59%
Teladoc Health
Aug 9, 2021
Maintains: Outperform
Price Target: $240 → $188
Current: $5.26
Upside: +3,474.14%
Oscar Health
Mar 29, 2021
Initiates: Market Perform
Price Target: $29
Current: $13.64
Upside: +112.61%